Literature DB >> 14499195

Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.

Jayanth Panyam1, Manisha M Dali, Sanjeeb K Sahoo, Wenxue Ma, Sudhir S Chakravarthi, Gordon L Amidon, Robert J Levy, Vinod Labhasetwar.   

Abstract

The objective of the study was to investigate the effect of particle size of nano- and microparticles formulated from poly(D,L-lactide-co-glycolide) (50:50 PLGA) on polymer degradation and protein release. Since the surface area to volume ratio is inversely proportional to the particle size, it is hypothesized that the particle size would influence the polymer degradation as well as the release of the encapsulated protein. PLGA nano- and microparticles of approximate mean diameters of 0.1, 1 and 10 microm, containing bovine serum albumin as a model protein, were formulated using a multiple water-in-oil-in-water emulsion solvent evaporation technique. These particles were incubated at 37 degrees C in phosphate-buffered saline (pH 7.4, 154 mM) and the particles were characterized at various time points for molecular weight of polymer, surface-associated polyvinyl alcohol content (PVA), and the particle surface topology using scanning electron microscopy. The supernatants from the above study were analyzed for the released protein and PVA content. Polymer degradation was found to be biphasic in both nano- and microparticles, with an initial rapid degradation for 20-30 days followed by a slower degradation phase. The 0.1 microm diameter nanoparticles demonstrated relatively higher polymer degradation rate (P<0.05) during the initial phase as compared to the larger size microparticles (first order degradation rate constants of 0.028 day(-1), 0.011 day(-1) and 0.018 day(-1) for 0.1, 1 and 10 microm particles, respectively), however the degradation rates were almost similar (0.008 to 0.009 day(-1)) for all size particles during the later phase. All size particles maintained their structural integrity during the initial degradation phase; however, this was followed by pore formation, deformation and fusion of particles during the slow degradation phase. Protein release from 0.1 and 1 microm particles was greater than that from 10 microm size particles. In conclusion, the polymer degradation rates in vitro were not substantially different for different size particles despite a 10- and 100-fold greater surface area to volume ratio for 0.1 microm size nanoparticles as compared to 1 and 10 microm size microparticles, respectively. Relatively higher amounts of the surface-associated PVA found in the smaller-size nanoparticles (0.1 microm) as compared to the larger-size microparticles could explain some of the observed degradation results with different size particles.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499195     DOI: 10.1016/s0168-3659(03)00328-6

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  88 in total

1.  Improved enzyme activity and stability in polymer microspheres by encapsulation of protein nanospheres.

Authors:  Brenda L Montalvo-Ortiz; Brian Sosa; Kai Griebenow
Journal:  AAPS PharmSciTech       Date:  2012-04-27       Impact factor: 3.246

Review 2.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

3.  PLGA/Ag nanocomposites: in vitro degradation study and silver ion release.

Authors:  E Fortunati; L Latterini; S Rinaldi; J M Kenny; I Armentano
Journal:  J Mater Sci Mater Med       Date:  2011-10-15       Impact factor: 3.896

4.  Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy.

Authors:  Sinjan De; Dennis H Robinson
Journal:  AAPS PharmSciTech       Date:  2004-09-13       Impact factor: 3.246

5.  Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.

Authors:  Hong Shen; Anne L Ackerman; Virginia Cody; Alessandra Giodini; Ella R Hinson; Peter Cresswell; Richard L Edelson; W Mark Saltzman; Douglas J Hanlon
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

6.  Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury.

Authors:  Yue Gao; Sivakumar Vijayaraghavalu; Melinda Stees; Brian K Kwon; Vinod Labhasetwar
Journal:  J Control Release       Date:  2019-03-28       Impact factor: 9.776

Review 7.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.

Authors:  Julie A Champion; Yogesh K Katare; Samir Mitragotri
Journal:  J Control Release       Date:  2007-04-11       Impact factor: 9.776

Review 8.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

9.  Unimolecular Micelle-Based Hybrid System for Perivascular Drug Delivery Produces Long-Term Efficacy for Neointima Attenuation in Rats.

Authors:  Guojun Chen; Xudong Shi; Bowen Wang; Ruosen Xie; Lian-Wang Guo; Shaoqin Gong; K Craig Kent
Journal:  Biomacromolecules       Date:  2017-06-14       Impact factor: 6.988

10.  Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

Authors:  Deepa A Rao; M Laird Forrest; Adam W G Alani; Glen S Kwon; Joseph R Robinson
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.